Koyfin Home > Directory > Health Care > Acceleron Pharma > Net Income

Acceleron Pharma Net Income Chart (XLRN)

Acceleron Pharma annual/quarterly Net Income from 2012 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Acceleron Pharma Net Income for the quarter ending June 06, 2020 was $-18m a -145.89% increase of 27m year over year
  • Acceleron Pharma Net Income for the last 12 months ending June 06, 2020 was $-138m a 1.68% decrease of -2m year over year
  • Acceleron Pharma Annual Net Income for 2019 was $-125m a 4.80% decrease of -6m from 2018
  • Acceleron Pharma Annual Net Income for 2018 was $-119m a 8.76% decrease of -10m from 2017
  • Acceleron Pharma Annual Net Income for 2017 was $-108m a 47.43% decrease of -51m from 2016
Other Income Statement Metrics:
  • Acceleron Pharma EBITDA for the quarter ending December 12, 2018 was $-36m a 25.58% decrease of -9m year over year
  • Acceleron Pharma Total Revenue for the quarter ending September 09, 2018 was $3m a -13.72% decrease of 0m year over year
View Chart On Koyfin

Quarterly XLRN Net Income Data

06/2020$-18m
03/2020$-51m
12/2019$-24m
09/2019$-45m
06/2019$-18m
03/2019$-38m
12/2018$-35m
09/2018$-29m
06/2018$-29m
03/2018$-26m

Annual XLRN Net Income Data

2019$-125m
2018$-119m
2017$-108m
2016$-57m
2015$-64m
2014$-51m
2013$-22m
2012$-33m
2011$36m